| Year |
Citation |
Score |
| 2019 |
Saminathan P, Kevadiya BD, Marker DF, Gendelman HE, Gorantla S, Gelbard HA. Broad Spectrum Mixed Lineage Kinase Type 3 Inhibition and HIV-1 Persistence in Macrophages. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 30617749 DOI: 10.1007/S11481-018-09829-8 |
0.612 |
|
| 2018 |
Bellizzi MJ, Hammond JW, Li H, Gantz Marker MA, Marker DF, Freeman RS, Gelbard HA. The Mixed-Lineage Kinase Inhibitor URMC-099 Protects Hippocampal Synapses in Experimental Autoimmune Encephalomyelitis. Eneuro. 5. PMID 30627663 DOI: 10.1523/ENEURO.0245-18.2018 |
0.554 |
|
| 2018 |
Hammond JW, Qiu WQ, Marker DF, Chamberlain JM, Greaves-Tunnell W, Bellizzi MJ, Lu SM, Gelbard HA. HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q. Glia. PMID 30325063 DOI: 10.1002/Glia.23511 |
0.613 |
|
| 2015 |
Puccini JM, Marker DF, Fitzgerald T, Barbieri J, Kim CS, Miller-Rhodes P, Lu SM, Dewhurst S, Gelbard HA. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 5271-83. PMID 25834052 DOI: 10.1523/Jneurosci.0650-14.2015 |
0.622 |
|
| 2014 |
Marker DF, Lu SM, Gelbard HA. Human immunodeficiency virus Microglia in Health and Disease. 373-392. DOI: 10.1007/978-1-4939-1429-6_15 |
0.468 |
|
| 2013 |
Tremblay MÈ, Marker DF, Puccini JM, Muly EC, Lu SM, Gelbard HA. Ultrastructure of microglia-synapse interactions in the HIV-1 Tat-injected murine central nervous system. Communicative & Integrative Biology. 6: e27670. PMID 24563721 DOI: 10.4161/Cib.27670 |
0.598 |
|
| 2013 |
Goodfellow VS, Loweth CJ, Ravula SB, Wiemann T, Nguyen T, Xu Y, Todd DE, Sheppard D, Pollack S, Polesskaya O, Marker DF, Dewhurst S, Gelbard HA. Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. Journal of Medicinal Chemistry. 56: 8032-48. PMID 24044867 DOI: 10.1021/Jm401094T |
0.582 |
|
| 2013 |
Marker DF, Tremblay MÈ, Puccini JM, Barbieri J, Gantz Marker MA, Loweth CJ, Muly EC, Lu SM, Goodfellow VS, Dewhurst S, Gelbard HA. The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 9998-10010. PMID 23761895 DOI: 10.1523/Jneurosci.0598-13.2013 |
0.615 |
|
| 2012 |
Marker DF, Puccini JM, Mockus TE, Barbieri J, Lu SM, Gelbard HA. LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein. Journal of Neuroinflammation. 9: 261. PMID 23190742 DOI: 10.1186/1742-2094-9-261 |
0.614 |
|
| 2011 |
Lu SM, Tremblay MÈ, King IL, Qi J, Reynolds HM, Marker DF, Varrone JJ, Majewska AK, Dewhurst S, Gelbard HA. HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. Plos One. 6: e23915. PMID 21912650 DOI: 10.1371/Journal.Pone.0023915 |
0.605 |
|
| 2010 |
Marker DF, Tremblay ME, Lu SM, Majewska AK, Gelbard HA. A thin-skull window technique for chronic two-photon in vivo imaging of murine microglia in models of neuroinflammation. Journal of Visualized Experiments : Jove. PMID 20972389 DOI: 10.3791/2059 |
0.544 |
|
| Show low-probability matches. |